icon
EquitySector - Healthcare

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth

3Y Annualised

24.57%

0.35% 1D

Fund Performance

Fund Multiplier

Fund Info

Peer Comparison

Fund Managers

AMC Details

Performance

1M Returns

0.50%

0.35% 1D

Benchmark

N/A

Fund Multiplier

Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)

This Fund

3 years 2 months

NIFTY 50

5 years 8 months

FD

9 years 7 months

Fund info

Fund size

₹4914.64 Cr

Min. SIP amount

₹100

Min. Lumpsum amount

₹5000

Exit load

0.01%

1% of the applicable NAV If units purchased or switched in from another scheme of the Fund are redeemed or switched out within 15 days from the date of allotment. NIL If units purchased or switched in from another scheme of the Fund are redeemed or switched out after 15 days from the date of allotment. Any redemption/switch arising out of excess holding by an investor beyond 25% of the net assets of the Scheme in the manner envisaged under specified SEBI Circular No. SEBI/IMD/CIR No. 10/22701/03 dated 12th December 2003, such redemption / switch will not be subject to exit load.

Risk Profile

Very High Risk

Fund Managers

PK
Priyanka KhandelwalFund Manager Since 12 Jul 2018
DK
Dharmesh KakkadFund Manager Since 2 May 2020

About ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth is a Equity mutual fund scheme from ICICI Prudential Asset Management Company Limited. This fund has been in existence for 6 years, having been launched on 2018-07-12. ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth has ₹4914.64 Cr worth of assets under management (AUM) as of Thu Apr 24 2025. The latest Net Asset Value (NAV) of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth as of Wed Apr 23 2025 is ₹40.4. The fund has an expense ratio of 1.18%, which is medium comparable to most other Equity funds.

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth returns for the last 1 year are 22.99%. Since launch, it has delivered 22.63% average annual returns.

The ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth has the majority of its money invested in Healthcare sectors.

Top 5 Holdings of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth.

  1. Sun Pharmaceuticals Industries Ltd: 13.50%
  2. Dr Reddy's Laboratories Ltd: 8.95%
  3. Cipla Ltd: 8.85%
  4. Divi's Laboratories Ltd: 6.71%
  5. Aurobindo Pharma Ltd: 5.30%

AMC Information

NameICICI Prudential Asset Management Company Limited
Founding Date2018-07-12
Email
Phone+91 22 26428000
Websitewww.icicipruamc.com
Address12th Floor, Narain Manzil, 23, Barakhamba Road,

Tax Implications of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth

Short Term Gains20% + applicable Surcharge + 4% Cess
Long Term Gains12.5% without indexation + applicable Surcharge + 4% Cess

Similar Funds from ICICI Prudential Asset Management Company Limited

Calculate Your Returns

Estimated Returns in 3 Years

₹0

Total Amount

₹0

Invest Nowcta image

FAQs

View All

It’s Time to Grow Your Wealth

₹1,000+ cr

AUM

1+ Lac

Investors

stack mb